HI
GSK icon

Hudock Inc’s GSK GSK Stock Holding History

Hudock Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,360
Closed -$128K – 361
2022
Q3 		$128K Buy
4,360
+411
+10% +$15.6K 0.04% 172
2022
Q2 		$214K Buy
3,949
+43
+1% +$2.37K 0.07% 134
2022
Q1 		$212K Buy
3,906
+20
+0.5% +$1.09K 0.06% 147
2021
Q4 		$214K Buy
3,886
+23
+0.6% +$1.2K 0.06% 155
2021
Q3 		$184K Buy
3,863
+22
+0.6% +$1.1K 0.06% 159
2021
Q2 		$191K Sell
3,841
-781
-17% -$37.5K 0.06% 156
2021
Q1 		$206K Buy
4,622
+34
+0.7% +$1.54K 0.06% 138
2020
Q4 		$211K Buy
4,588
+822
+22% +$37.8K 0.07% 135
2020
Q3 		$177K Buy
3,766
+19
+0.5% +$952 0.07% 134
2020
Q2 		$191K Buy
3,747
+24
+0.6% +$1.23K 0.07% 117
2020
Q1 		$176K Sell
3,723
-63
-2% -$3.36K 0.07% 101
2019
Q4 		$222K Buy
3,786
+17
+0.5% +$946 0.07% 106
2019
Q3 		$201K Buy
3,769
+19
+0.5% +$977 0.07% 106
2019
Q2 		$187K Buy
3,750
+16
+0.4% +$803 0.07% 111
2019
Q1 		$195K Buy
3,734
+480
+15% +$24K 0.07% 112
2018
Q4 		$155K Buy
3,254
+1,955
+151% +$96.3K 0.06% 114
2018
Q3 		$65K Buy
1,299
+85
+7% +$4.32K 0.03% 212
2018
Q2 		$61K Sell
1,214
-236
-16% -$11.9K 0.02% 210
2018
Q1 		$70K Buy
1,450
+18
+1% +$838 0.03% 200
2017
Q4 		$63K Buy
1,432
+98
+7% +$4.53K 0.03% 212
2017
Q3 		$67K Buy
1,334
+141
+12% +$7.15K 0.03% 200
2017
Q2 		$64K Buy
1,193
+11
+0.9% +$586 0.03% 196
2017
Q1 		$62K Buy
1,182
+6
+0.5% +$304 0.03% 194
2016
Q4 		$56K Buy
1,176
+246
+26% +$12.2K 0.03% 203
2016
Q3 		$50K Buy
930
+6
+0.6% +$329 0.03% 221
2016
Q2 		$50K Buy
924
+15
+2% +$790 0.03% 226
2016
Q1 		$46K Buy
909
+7
+0.8% +$349 0.03% 237
2015
Q4 		$45K Buy
902
+8
+0.9% +$408 0.02% 225
2015
Q3 		$43K Buy
894
+6
+0.7% +$312 0.02% 231
2015
Q2 		$46K Buy
888
+7
+0.8% +$394 0.02% 218
2015
Q1 		$51K Buy
881
+7
+0.8% +$401 0.02% 207
2014
Q4 		$47K Buy
874
+7
+0.8% +$392 0.02% 215
2014
Q3 		$50K Buy
867
+149
+21% +$9.13K 0.03% 206
2014
Q2 		$48K Buy
718
+7
+1% +$474 0.05% 211
2014
Q1 		$48K Buy
711
+5
+0.7% +$338 0.04% 201
2013
Q4 		$47K Buy
706
+5
+0.7% +$324 0.04% 196
2013
Q3 		$44K Buy
701
+5
+0.7% +$322 0.04% 170
2013
Q2 		$43K Buy
+696
New +$44.2K 0.06% 175

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Hudock Inc's GSK Position: Q4 2022 in Review

Hudock Inc sold out of GSK (GSK) in Q4 2022, closing a stake of 4,360 shares — an estimated $128K sold.

Hudock Inc first reported a position in GSK in Q2 2013 and held it in 38 quarters. The position peaked at $222K in Q4 2019. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Hudock Inc reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 4,360 GSK shares in Q4 2022, an estimated $128K.
  • Hudock Inc first reported a position in GSK in Q2 2013 and held it in 38 quarters.
  • Hudock Inc's GSK position peaked at $222K in Q4 2019.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.